Literature DB >> 24650449

Chronic stress accelerates pancreatic cancer growth and invasion: a critical role for beta-adrenergic signaling in the pancreatic microenvironment.

Corina Kim-Fuchs1, Caroline P Le2, Matthew A Pimentel2, David Shackleford3, Davide Ferrari4, Eliane Angst5, Frédéric Hollande6, Erica K Sloan7.   

Abstract

Pancreatic cancer cells intimately interact with a complex microenvironment that influences pancreatic cancer progression. The pancreas is innervated by fibers of the sympathetic nervous system (SNS) and pancreatic cancer cells have receptors for SNS neurotransmitters which suggests that pancreatic cancer may be sensitive to neural signaling. In vitro and non-orthotopic in vivo studies showed that neural signaling modulates tumour cell behavior. However the effect of SNS signaling on tumor progression within the pancreatic microenvironment has not previously been investigated. To address this, we used in vivo optical imaging to non-invasively track growth and dissemination of primary pancreatic cancer using an orthotopic mouse model that replicates the complex interaction between pancreatic tumor cells and their microenvironment. Stress-induced neural activation increased primary tumor growth and tumor cell dissemination to normal adjacent pancreas. These effects were associated with increased expression of invasion genes by tumor cells and pancreatic stromal cells. Pharmacological activation of β-adrenergic signaling induced similar effects to chronic stress, and pharmacological β-blockade reversed the effects of chronic stress on pancreatic cancer progression. These findings indicate that neural β-adrenergic signaling regulates pancreatic cancer progression and suggest β-blockade as a novel strategy to complement existing therapies for pancreatic cancer.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Beta-adrenergic; Beta-blocker; Chronic stress; Invasion; Pancreatic cancer; Tumor microenvironment

Mesh:

Substances:

Year:  2014        PMID: 24650449      PMCID: PMC4102665          DOI: 10.1016/j.bbi.2014.02.019

Source DB:  PubMed          Journal:  Brain Behav Immun        ISSN: 0889-1591            Impact factor:   7.217


  60 in total

1.  Chronic stress enhances progression of acute lymphoblastic leukemia via β-adrenergic signaling.

Authors:  Donald M Lamkin; Erica K Sloan; Ami J Patel; Beverley S Chiang; Matthew A Pimentel; Jeffrey C Y Ma; Jesusa M Arevalo; Kouki Morizono; Steve W Cole
Journal:  Brain Behav Immun       Date:  2012-01-25       Impact factor: 7.217

2.  Surgery for recurrent pancreatic ductal adenocarcinoma.

Authors:  Jörg Kleeff; Carolin Reiser; Ulf Hinz; Jeannine Bachmann; Jürgen Debus; Dirk Jaeger; Helmut Friess; Markus W Büchler
Journal:  Ann Surg       Date:  2007-04       Impact factor: 12.969

3.  The tobacco-specific carcinogen, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone stimulates proliferation of immortalized human pancreatic duct epithelia through beta-adrenergic transactivation of EGF receptors.

Authors:  Minoo D F Askari; Ming-Sound Tsao; Hildegard M Schuller
Journal:  J Cancer Res Clin Oncol       Date:  2005-10-20       Impact factor: 4.553

4.  Clinical significance of the genetic landscape of pancreatic cancer and implications for identification of potential long-term survivors.

Authors:  Shinichi Yachida; Catherine M White; Yoshiki Naito; Yi Zhong; Jacqueline A Brosnan; Anne M Macgregor-Das; Richard A Morgan; Tyler Saunders; Daniel A Laheru; Joseph M Herman; Ralph H Hruban; Alison P Klein; Siân Jones; Victor Velculescu; Christopher L Wolfgang; Christine A Iacobuzio-Donahue
Journal:  Clin Cancer Res       Date:  2012-09-18       Impact factor: 12.531

5.  The sympathetic nervous system induces a metastatic switch in primary breast cancer.

Authors:  Erica K Sloan; Saul J Priceman; Benjamin F Cox; Stephanie Yu; Matthew A Pimentel; Veera Tangkanangnukul; Jesusa M G Arevalo; Kouki Morizono; Breanne D W Karanikolas; Lily Wu; Anil K Sood; Steven W Cole
Journal:  Cancer Res       Date:  2010-09-07       Impact factor: 12.701

6.  Pancreatic stellate cells: partners in crime with pancreatic cancer cells.

Authors:  Alain Vonlaufen; Swapna Joshi; Changfa Qu; Phoebe A Phillips; Zhihong Xu; Nicole R Parker; Cheryl S Toi; Romano C Pirola; Jeremy S Wilson; David Goldstein; Minoti V Apte
Journal:  Cancer Res       Date:  2008-04-01       Impact factor: 12.701

7.  Stress-induced changes attributable to the sympathetic nervous system during experimental influenza viral infection in DBA/2 inbred mouse strain.

Authors:  G Hermann; F M Beck; C A Tovar; W B Malarkey; C Allen; J F Sheridan
Journal:  J Neuroimmunol       Date:  1994-09       Impact factor: 3.478

8.  Randomised, placebo-controlled, double-blind, parallel-group phase III study evaluating aflibercept in patients receiving first-line treatment with gemcitabine for metastatic pancreatic cancer.

Authors:  Philippe Rougier; Hanno Riess; Robert Manges; Petr Karasek; Yves Humblet; Carlo Barone; Armando Santoro; Sylvie Assadourian; Laurence Hatteville; Philip A Philip
Journal:  Eur J Cancer       Date:  2013-04-30       Impact factor: 9.162

9.  Pancreatic stellate cells: a starring role in normal and diseased pancreas.

Authors:  Minoti V Apte; Romano C Pirola; Jeremy S Wilson
Journal:  Front Physiol       Date:  2012-08-28       Impact factor: 4.566

10.  High levels of untreated distress and fatigue in cancer patients.

Authors:  L E Carlson; M Angen; J Cullum; E Goodey; J Koopmans; L Lamont; J H MacRae; M Martin; G Pelletier; J Robinson; J S A Simpson; M Speca; L Tillotson; B D Bultz
Journal:  Br J Cancer       Date:  2004-06-14       Impact factor: 7.640

View more
  88 in total

Review 1.  Sympathetic nervous system regulation of the tumour microenvironment.

Authors:  Steven W Cole; Archana S Nagaraja; Susan K Lutgendorf; Paige A Green; Anil K Sood
Journal:  Nat Rev Cancer       Date:  2015-09       Impact factor: 60.716

2.  C/EBPβ regulates the M2 transcriptome in β-adrenergic-stimulated macrophages.

Authors:  Donald M Lamkin; Shreyesi Srivastava; Karen P Bradshaw; Jenna E Betz; Kevin B Muy; Anna M Wiese; Shelby K Yee; Rebecca M Waggoner; Jesusa M G Arevalo; Alexander J Yoon; Kym F Faull; Erica K Sloan; Steve W Cole
Journal:  Brain Behav Immun       Date:  2019-05-24       Impact factor: 7.217

3.  Cancer cells become less deformable and more invasive with activation of β-adrenergic signaling.

Authors:  Tae-Hyung Kim; Navjot Kaur Gill; Kendra D Nyberg; Angelyn V Nguyen; Sophia V Hohlbauch; Nicholas A Geisse; Cameron J Nowell; Erica K Sloan; Amy C Rowat
Journal:  J Cell Sci       Date:  2016-11-14       Impact factor: 5.285

4.  Impact of Concurrent Medication Use on Pancreatic Cancer Survival-SEER-Medicare Analysis.

Authors:  Muhammad S Beg; Arjun Gupta; David Sher; Sadia Ali; Saad Khan; Ang Gao; Tyler Stewart; Chul Ahn; Jarett Berry; Eric M Mortensen
Journal:  Am J Clin Oncol       Date:  2018-08       Impact factor: 2.339

5.  Propranolol inhibits molecular risk markers in HCT recipients: a phase 2 randomized controlled biomarker trial.

Authors:  Jennifer M Knight; J Douglas Rizzo; Parameswaran Hari; Marcelo C Pasquini; Karen E Giles; Anita D'Souza; Brent R Logan; Mehdi Hamadani; Saurabh Chhabra; Binod Dhakal; Nirav Shah; Deepika Sriram; Mary M Horowitz; Steve W Cole
Journal:  Blood Adv       Date:  2020-02-11

6.  Postdiagnostic use of β-blockers and other antihypertensive drugs and the risk of recurrence and mortality in head and neck cancer patients: an observational study of 10,414 person-years of follow-up.

Authors:  S-A Kim; H Moon; J-L Roh; S-B Kim; S-H Choi; S Y Nam; S Y Kim
Journal:  Clin Transl Oncol       Date:  2017-01-16       Impact factor: 3.405

7.  Upregulation of RET induces perineurial invasion of pancreatic adenocarcinoma.

Authors:  M Amit; S Na'ara; L Leider-Trejo; Y Binenbaum; N Kulish; E Fridman; A Shabtai-Orbach; R J Wong; Z Gil
Journal:  Oncogene       Date:  2017-01-16       Impact factor: 9.867

Review 8.  GPCRs in pancreatic adenocarcinoma: Contributors to tumour biology and novel therapeutic targets.

Authors:  Krishna Sriram; Cristina Salmerón; Shu Z Wiley; Paul A Insel
Journal:  Br J Pharmacol       Date:  2020-04-12       Impact factor: 8.739

9.  Role of host β1- and β2-adrenergic receptors in a murine model of B16 melanoma: functional involvement of β3-adrenergic receptors.

Authors:  Federica Sereni; Massimo Dal Monte; Luca Filippi; Paola Bagnoli
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-08-19       Impact factor: 3.000

Review 10.  Unintended Effects of GPCR-Targeted Drugs on the Cancer Phenotype.

Authors:  Abigail C Cornwell; Michael E Feigin
Journal:  Trends Pharmacol Sci       Date:  2020-10-22       Impact factor: 14.819

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.